Form 8-K - Current report:
SEC Accession No. 0001193125-26-253784
Filing Date
2026-06-02
Accepted
2026-06-02 17:00:32
Documents
12
Period of Report
2026-05-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d149753d8k.htm   iXBRL 8-K 44895
2 EX-10.1 d149753dex101.htm EX-10.1 121008
  Complete submission text file 0001193125-26-253784.txt   315575

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sttk-20260528.xsd EX-101.SCH 3192
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sttk-20260528_lab.xml EX-101.LAB 17992
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sttk-20260528_pre.xml EX-101.PRE 11269
15 EXTRACTED XBRL INSTANCE DOCUMENT d149753d8k_htm.xml XML 3632
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39593 | Film No.: 261057319
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)